Literature DB >> 9922053

Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia.

B Arun1, B Berberian, N Azumi, S R Frankel, H Luksenburg, C Freter.   

Abstract

A 46 year old male with acute promyelocytic leukemia treated with all-trans retinoic acid (ATRA), developed fever, bilateral erythematous nodules in his axillary area, lower abdomen and inguinal region. Histopathologic examination of the skin biopsy revealed dense neutrophil infiltration in the dermis without vasculitis. The diagnosis of Sweet's syndrome was made. High dose methylprednisolone was administered and the lesions started to improve within 24 hours.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9922053     DOI： 10.3109/10428199809057622

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


  8 in total

1.  Characteristics of Sweet Syndrome in patients with acute myeloid leukemia.

Authors:  Syed M Kazmi; Naveen Pemmaraju; Keyur P Patel; Philip R Cohen; Naval Daver; Kathy M Tran; Farhad Ravandi; Madeleine Duvic; Guillermo Garcia-Manero; Sherry Pierce; Aziz Nazha; Gautam Borthakur; Hagop Kantarjian; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-12-24

2.  Genital ulcer development in patients with acute promyelocytic leukaemia treated with all-trans retinoic Acid: a case series.

Authors:  Mohammed Al Huneini; Fauzia Wasim; Khalil Al Farsi; Murtadha Al-Khabori; Salam Al Kindi
Journal:  Oman Med J       Date:  2013-05

3.  Genital vasculitis secondary to all-trans-retinoic-acid.

Authors:  Uday Yanamandra; Alka Khadwal; Uma Nahar Saikia; Pankaj Malhotra
Journal:  BMJ Case Rep       Date:  2016-01-20

4.  Scrotal ulceration following all-trans retinoic Acid therapy for acute promyelocytic leukemia.

Authors:  Illias Tazi; Mohamed Rachid; Asmaa Quessar; Said Benchekroun
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

5.  A Rare Case of Midostaurin-Associated Sweet's Syndrome.

Authors:  Hesham Yasin; Tessa Laytem; Grerk Sutamtewagul; Sabarish Ayyappan
Journal:  Case Rep Hematol       Date:  2022-04-22

6.  Sweet's syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid.

Authors:  C J Park; Y D Bae; J Y Choi; P S Heo; K S Lee; Y S Park; J A Lee
Journal:  Korean J Intern Med       Date:  2001-09       Impact factor: 2.884

7.  Increase of a wide range of bioactive substances in an active phase of neuro-Sweet disease.

Authors:  Hiroi Kusaka; Katsuya Nagatani; Takeo Sato; Seiji Minota
Journal:  BMJ Case Rep       Date:  2020-04-08

Review 8.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.